Segall Bryant & Hamill’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Segall Bryant & Hamill's VCYT Position: Q2 2026 in Review
Segall Bryant & Hamill increased its Veracyte (VCYT) stake by 7.1% in Q2 2026, buying an estimated $1.75M and bringing the position to 633,227 shares worth $37.2M. The position accounts for 0.44% of the portfolio, ranked #49.
Segall Bryant & Hamill first reported a position in VCYT in Q1 2021 and has held it in 22 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Segall Bryant & Hamill held 633,227 shares of Veracyte worth $37.2M as of Q2 2026.
- Segall Bryant & Hamill bought 41,739 Veracyte shares in Q2 2026, an estimated $1.75M.
- Veracyte made up 0.44% of Segall Bryant & Hamill's portfolio in Q2 2026, its #49 holding.
- Segall Bryant & Hamill first reported a position in Veracyte in Q1 2021 and has held it in 22 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.